These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34057670)

  • 1. Acquired hypofibrinogenemia in a patient with multiple myeloma.
    Inano S; Oku Y; Aiba A; Kawasaki N; Okamoto Y; Yuhi N; Shibata S; Takiuchi Y; Tabata S; Kitano T
    Int J Hematol; 2021 Sep; 114(3):395-400. PubMed ID: 34057670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired dysfibrinogenemia secondary to multiple myeloma.
    Kotlín R; Sobotková A; Riedel T; Salaj P; Suttnar J; Reicheltová Z; Májek P; Khaznadar T; Dyr JE
    Acta Haematol; 2008; 120(2):75-81. PubMed ID: 18841003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viscoelastic Signals for Optimal Resuscitation in Trauma: Kaolin Thrombelastography Cutoffs for Diagnosing Hypofibrinogenemia (VISOR Study).
    Chow JH; Richards JE; Morrison JJ; Galvagno SM; Tanaka KA; Madurska MJ; Rock P; Scalea TM; Mazzeffi MA
    Anesth Analg; 2019 Dec; 129(6):1482-1491. PubMed ID: 31743167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bleeding due to acquired dysfibrinogenemia as the initial presentation of multiple myeloma.
    Siddiq N; Bergstrom C; Anderson LD; Nagalla S
    BMJ Case Rep; 2019 Jul; 12(7):. PubMed ID: 31320370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of acquired dysfibrinogenemia in multiple myeloma treated with therapeutic plasma exchange.
    Post GR; James L; Alapat D; Guillory V; Cottler-Fox M; Nakagawa M
    Transfus Apher Sci; 2013 Feb; 48(1):35-8. PubMed ID: 22842111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired dysfibrinogenemia caused by monoclonal production of immunoglobulin lambda light chain.
    Dear A; Brennan SO; Sheat MJ; Faed JM; George PM
    Haematologica; 2007 Nov; 92(11):e111-7. PubMed ID: 18024387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of hypofibrinogenemia during cardiac surgery: a comparison of resonance-based thrombelastography with the traditional Clauss method.
    Magunia H; Azizy E; Krautter L; Rosenberger P; Straub A
    Blood Coagul Fibrinolysis; 2020 Dec; 31(8):551-557. PubMed ID: 33141779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Fibrinogen Determination Methods in Differential Diagnosis of Hypofibrinogenemia and Dysfibrinogenemia.
    Skornova I; Simurda T; Stasko J; Horvath D; Zolkova J; Holly P; Brunclikova M; Samos M; Bolek T; Schnierer M; Slavik L; Kubisz P
    Clin Lab; 2021 Apr; 67(4):. PubMed ID: 33865248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of hypofibrinogenemias found on routine coagulation screening tests and identification of heterozygous dysfibrinogenemia or fibrinogen deficiency].
    Hirota-Kawadobora M; Ishikawa S; Fujihara N; Wakabayashi S; Kamijo Y; Yamauchi K; Terasawa F; Okumura N; Katsuyama T
    Rinsho Byori; 2007 Nov; 55(11):989-95. PubMed ID: 18154029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital hypofibrinogenemia and recurrent placental abruption.
    Ness PM; Budzynski AZ; Olexa SA; Rodvien R
    Obstet Gynecol; 1983 Apr; 61(4):519-23. PubMed ID: 6828283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Whether fibrinogen concentrates are necessary in Russia?].
    Galstian GM; Berkovskiĭ AL; Zhuravlev VV; Polokhov DM; Savchenko VG
    Anesteziol Reanimatol; 2014; (3):49-59. PubMed ID: 25306685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired factor XIII activation in patients with congenital afibrinogenemia.
    Bridey F; Négrier C; Duval C; Ariëns R; de Moerloose P; Casini A
    Haematologica; 2019 Mar; 104(3):e111-e113. PubMed ID: 30262556
    [No Abstract]   [Full Text] [Related]  

  • 13. Screening method for congenital dysfibrinogenemia using clot waveform analysis with the Clauss method.
    Arai S; Kamijo T; Hayashi F; Shinohara S; Arai N; Sugano M; Uehara T; Honda T; Okumura N
    Int J Lab Hematol; 2021 Apr; 43(2):281-289. PubMed ID: 33030793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant γY278H Fibrinogen Showed Normal Secretion from CHO Cells, but a Corresponding Heterozygous Patient Showed Hypofibrinogenemia.
    Kamijo T; Kaido T; Yoda M; Arai S; Yamauchi K; Okumura N
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired Dysfibrinogenemia Caused by Autoantibody Inhibiting Fibrin Polymerization in a Patient with MELAS Syndrome and Bleeding Tendency.
    Lee N; Kim JE; Yoo HJ; Gu J; Kim H; Chung J; Koh Y; Kim HK
    Ann Clin Lab Sci; 2016 Dec; 46(6):696-700. PubMed ID: 27993886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary Hypofibrinogenemia with Hepatic Storage.
    Asselta R; Paraboschi EM; Duga S
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33105716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of afibrinogenemia in a chihuahua.
    Chambers G
    J Am Anim Hosp Assoc; 2013; 49(1):70-4. PubMed ID: 23148136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the efficacy of two human fibrinogen concentrates to treat dilutional coagulopathy in vitro.
    Haas T; Cushing MM; Asmis LM
    Scand J Clin Lab Invest; 2018 May; 78(3):230-235. PubMed ID: 29446989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired dysfibrinogenemia: monoclonal λ-type IgA binding to fibrinogen caused lower functional plasma fibrinogen level and abnormal clot formation.
    Arai S; Kamijo T; Takezawa Y; Sugano M; Nakazawa H; Yanagisawa R; Uehara T; Honda T; Okumura N
    Int J Hematol; 2020 Jul; 112(1):96-104. PubMed ID: 32253663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of hypofibrinogenemia in blunt trauma patients on admission.
    Kimura Y; Kimura S; Sumita S; Yamakage M
    J Anesth; 2015 Apr; 29(2):242-8. PubMed ID: 25112812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.